HIGH ALERT: Please read the COMMENTS very carefully.
rituximab
Preferred biosimilar agent for Inpatient and Outpatient use: Ruxience (-pvvr)
Non-Preferred agents will only be procured for scheduled infusion patients with an approved PA whose insurance will not cover our preferred agent(s).
Add Formweb to your mobile device
Preferred biosimilar agent for Inpatient and Outpatient use: Ruxience (-pvvr)
Non-Preferred agents will only be procured for scheduled infusion patients with an approved PA whose insurance will not cover our preferred agent(s).